疫苗特性不确定时如何为政策制定建模疫苗影响:泰国在COVID-19大流行疫苗推广前的案例研究
泰国在2021年初面临第一波有限COVID-19疫苗应优先接种哪一群体的困境,当时该国发病率和死亡率均较低。研究采用数学建模分析,比较将可用剂量分配给高重症组(65岁以上)或高传播组(20-39岁)的短期潜在影响,并探索了不同疫苗特性场景。模型提示,若以减少死亡为优先,应优先接种高重症组;而高传播组接种对感染保护力足够高(超过70%)的疫苗时,可产生足够群体效应以推迟预期流行高峰,并减少两组病例和死亡。
要点
- 模型比较了将有限疫苗剂量分配给高重症组(65岁以上)或高传播组(20-39岁)的短期影响。
- 若以减少死亡为优先,模型提示应优先接种高重症组,该组直接减少死亡数而发病和住院数不变。
- 高传播组接种对感染保护力超过70%的疫苗时,可产生足够群体效应以推迟流行高峰并减少两组病例和死亡。
核心结论
- 基于当时疫苗降低感染严重程度的证据,模型提示若以减少死亡为优先,应优先接种高重症组。
- 高传播组接种对感染保护力超过70%的疫苗时,可产生足够群体效应以推迟预期流行高峰,并减少两组病例和死亡。
研究设计与样本
- 研究为数学建模分析,比较将可用剂量分配给高重症组(65岁以上)或高传播组(20-39岁)的短期潜在影响。
- 分析探索了不同严重程度和传播减少水平的疫苗特性场景,模型时间范围为12个月。
主要发现
- 接种高重症组对减少死亡数有直接影响,而发病数和住院数保持不变。
- 高传播组接种对感染保护力超过70%的疫苗时,可产生足够群体效应以推迟预期流行高峰,并减少两组病例和死亡。
临床怎么用
- 这些分析有助于为泰国2021年全年的疫苗接种策略提供信息,并可为疫苗特性不确定时用于政策制定的未来建模研究提供参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thailand faced a dilemma of which groups to prioritise with a limited first tranche of COVID-19 vaccinations in early 2021, at a time when there was low incidence and low mortality in the country. A mathematical modelling analysis was performed to compare the potential short-term impact of allocating the available doses to either the high severity group (over 65-year-olds) or the high transmission group (aged 20-39). At the time of the analysis, there was uncertainty about the precise characteristics of the vaccines available, in terms of their potential impact on transmission and reductions to the severity of infection. As such, a range of vaccine characteristic scenarios, with differing levels of severity and transmission reductions were explored. Using the evidence available at the time regarding severity reduction of infection due to the vaccines, the model suggested that vaccinating high severity group should be the priority if reductions in deaths is the priority. Vaccinating this group was found to have a direct impact on reducing the number of deaths, while the incidence and hospitalisations remained unchanged. However, the model found that vaccinating the high transmission group with a vaccine with sufficiently high protection against infection (more than 70%) could provide enough herd effects to delay the expected epidemic peak, resulting in both case and death reductions in both target groups. The model explored a 12-month time horizon. These analyses helped to inform the vaccination strategy in Thailand throughout 2021 and can inform future modelling studies for policymaking when the characteristics of vaccines are uncertain.
引用
- Luangasanatip N, Painter C, Pan-Ngum W, et al. How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic. Vaccine. 2023. PMID: 37365059. doi:10.1016/j.vaccine.2023.06.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。